See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Pope Francis
Donald Trump
Vladimir Putin
Elon Musk
Immigration
CPAC
Basketball
Vatican
Wrestling
Baseball
MLS
Tennis
Published • loading... • Updated

Benefits, Risks With EBRT Plus SADT in Intermediate-Risk Prostate Cancer

Summary by oncnursingnews.com
Increase in QOL and decrease in sexual function are among the benefits and risks, respectively, of adding SADT to EBRT for intermediate-risk prostate cancer.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
oncnursingnews.comoncnursingnews.com

Benefits, Risks With EBRT Plus SADT in Intermediate-Risk Prostate Cancer

Increase in QOL and decrease in sexual function are among the benefits and risks, respectively, of adding SADT to EBRT for intermediate-risk prostate cancer.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

oncnursingnews.com broke the news in on Friday, February 14, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
Search
BlindspotLocal